Detalhe da pesquisa
1.
Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial.
Hepatology
; 75(1): 182-195, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34396571
2.
Tolerability, pharmacokinetics and antiviral activity of rHSA/IFNα2a for the treatment of chronic hepatitis B infection.
Br J Clin Pharmacol
; 83(5): 1056-1071, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27862178
3.
Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues.
Gut
; 65(2): 313-20, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25586058
4.
Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study.
J Hepatol
; 65(4): 674-682, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27238752
5.
Nationwide survey of specialist knowledge on current standard of care (Peg-IFN/RBV) and barriers of care in chronic hepatitis C patients in China.
J Gastroenterol Hepatol
; 31(12): 1995-2003, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27043040
6.
Sustained viral response and treatment-induced cytopenia correlate with SLCs and KLF12 genotypes in interferon/ribavirin-treated Chinese chronic hepatitis C patients.
J Gastroenterol Hepatol
; 31(8): 1489-97, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26750805
7.
Use of parenteral caffeinum natrio-benzoicum: an underestimated risk factor for HCV transmission in China.
BMC Public Health
; 15: 928, 2015 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26386815
8.
[The efficacy and prognostic predictors of different treatment courses with pegylated interferon α-2a and ribavirin combination in recurrent chronic hepatitis C patients].
Zhonghua Nei Ke Za Zhi
; 54(8): 699-704, 2015 Aug.
Artigo
em Zh
| MEDLINE | ID: mdl-26674626
9.
Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China.
Clin Infect Dis
; 44(4): 541-8, 2007 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17243057
10.
[A multicenter, randomized, open-label study of the safety and effectiveness of pegylated interferon alpha 2b and interferon alpha 2b in treating HBeAg positive chronic hepatitis B patients].
Zhonghua Gan Zang Bing Za Zhi
; 14(5): 323-6, 2006 May.
Artigo
em Zh
| MEDLINE | ID: mdl-16732903
11.
Test of IL28B polymorphisms in chronic hepatitis C patients treated with PegIFN and ribavirin depends on HCV genotypes: results from a meta-analysis.
PLoS One
; 7(9): e45698, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23029188
12.
Characterization of full-length enterovirus 71 strains from severe and mild disease patients in northeastern China.
PLoS One
; 7(3): e32405, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22479324